Standex International
SXI
288.25
-8.87
-2.99%
Standex International
US · SXI
#2370 by market cap
Listed 1970
288.25
-8.87
-2.99%
Live - 5344 symbols - heartbeat 358s ago
· 2026-10-08 06:32
Pre-market
285.00
-1.13%
After-hours
288.25
0.00%
- Market cap
- 3.54B
- P/E (TTM)i
- 33.25
- P/Bi
- 4.69
- EPSi
- 8.67
- Div yieldi
- 0.46%
- 52W posi
- 49%
Reader sentiment
Are you bullish or bearish on SXI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.75, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +12.85% YoY
Margins
- Gross margin
- 41.73%
- Operating margin
- 17.13%
- Net margin
- 11.74%
Key ratios & quality
- Enterprise valuei
- 3.89B
- Altman Z-Scorei
- 4.75
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 639.93M | 604.54M | 656.23M | 735.34M | 741.05M | 720.64M | 790.11M | 891.60M |
| Gross profit | 234.67M | 215.46M | 241.26M | 269.95M | 285.10M | 282.00M | 315.25M | 372.03M |
| Selling & admin expenses | 150.33M | 148.50M | 163.06M | 169.89M | 172.34M | 169.60M | 193.36M | 219.29M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 83.84M | 66.96M | 78.20M | 94.31M | 113.37M | 112.29M | 121.89M | 152.74M |
| Pretax profit | 66.97M | 54.07M | 52.70M | 81.29M | 163.95M | 95.12M | 68.81M | 162.94M |
| Tax | 18.69M | 13.06M | 14.16M | 19.81M | 24.80M | 21.53M | 11.08M | 34.25M |
| Net profit | 67.91M | 20.19M | 36.47M | 61.39M | 138.99M | 73.07M | 57.68M | 128.54M |
| Basic EPS | 5 | 2 | 3 | 5 | 12 | 6 | 5 | 9 |
| Diluted EPS | 5.38 | 1.63 | 2.97 | 5.06 | 11.58 | 6.14 | 4.64 | 8.67 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 207.78M | 222.05M | 217.43M | 221.32M | 224.60M | 228.25M |
| Gross profit | 82.43M | 91.30M | 90.43M | 92.23M | 91.93M | 97.44M |
| Selling & admin expenses | 52.05M | 52.60M | 54.37M | 55.61M | 52.44M | 56.88M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 30.38M | 38.70M | 36.06M | 36.63M | 39.49M | 40.56M |
| Pretax profit | 17.58M | 26.08M | 20.99M | 27.17M | 82.67M | 32.11M |
| Tax | -5.20M | 10.61M | 5.17M | 6.54M | 14.04M | 8.52M |
| Net profit | 22.73M | 15.49M | 15.80M | 20.68M | 68.52M | 23.55M |
| Basic EPS | 2 | 1 | 1 | 0 | 6 | 2 |
| Diluted EPS | 1.81 | 1.23 | 1.25 | 0.17 | 5.55 | 1.69 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 333.87M | 332.00M | 374.37M | 379.00M | 483.25M | 430.10M | 480.88M | 551.76M |
| Cash & ST investments | 93.15M | 118.81M | 136.37M | 104.84M | 195.71M | 154.20M | 104.54M | 178.73M |
| Inventory | 76.30M | 85.03M | 91.86M | 105.34M | 98.54M | 87.11M | 129.99M | 128.96M |
| Total assets | 921.89M | 930.88M | 962.22M | 934.44M | 1.02B | 1.01B | 1.57B | 1.59B |
| Total current liabilities | 141.62M | 122.88M | 143.71M | 150.77M | 140.97M | 127.57M | 166.98M | 229.52M |
| Short-term debt | -- | 8.02M | 7.93M | 7.89M | 8.04M | 8.29M | 11.13M | 12.53M |
| Long-term debt | 197.61M | 199.15M | 199.49M | 174.83M | 173.44M | 148.88M | 552.52M | 517.95M |
| Total liabilities | 457,576,000.00 | 469,246,000.00 | 455,798,000.00 | 435,096,000.00 | 417,480,000.00 | 383,554,000.00 | 827,290,000.00 | 830,494,000.00 |
| Total equity | 464.31M | 461.63M | 506.43M | 499.34M | 607.45M | 621.50M | 739.59M | 755.21M |
| Retained earnings | 818.28M | 827.66M | 852.49M | 901.42M | 1.03B | 1.09B | 1.13B | 1.22B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 486.89M | 480.88M | 487.57M | 490.73M | 482.72M | 551.76M |
| Cash & ST investments | 109.81M | 104.54M | 98.65M | 97.00M | 103.73M | 178.73M |
| Inventory | 119.97M | 129.99M | 135.78M | 131.20M | 129.56M | 128.96M |
| Total assets | 1.55B | 1.57B | 1.55B | 1.55B | 1.53B | 1.59B |
| Total current liabilities | 143.07M | 166.98M | 169.70M | 170.81M | 158.41M | 229.52M |
| Short-term debt | 10.00M | 11.13M | 11.74M | 12.74M | 12.48M | 12.53M |
| Long-term debt | 579.41M | 552.52M | 544.62M | 534.73M | 472.84M | 517.95M |
| Total liabilities | 840,056,000.00 | 827,290,000.00 | 820,056,000.00 | 809,754,000.00 | 728,371,000.00 | 830,494,000.00 |
| Total equity | 714.50M | 739.59M | 734.81M | 744.75M | 798.41M | 755.21M |
| Retained earnings | 1.12B | 1.13B | 1.14B | 1.14B | 1.20B | 1.22B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 73.35M | 47.24M | 83.58M | 77.72M | 90.80M | 92.66M | 69.60M | 89.56M |
| Depreciation & amortization | 29.29M | 32.29M | 33.24M | 29.70M | 28.47M | 28.14M | 35.44M | 38.65M |
| Free cash flow | 40.84M | 25.72M | 61.83M | 53.83M | 66.53M | 72.36M | 41.25M | 64.36M |
| Dividends paid | -9.83M | -10.61M | -11.45M | -12.25M | -12.99M | -13.90M | -15.03M | -16.19M |
| Stock buybacks / issuance | -33.39M | -10.44M | -21.20M | -31.43M | -25.53M | -31.82M | -9.91M | -4.40M |
| Ending cash balance | 93.15M | 118.81M | 136.37M | 104.84M | 195.71M | 154.20M | 104.54M | 178.73M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 9.54M | 33.42M | 16.83M | 20.56M | 11.75M | 40.43M |
| Depreciation & amortization | 9.74M | 10.13M | 9.82M | 9.98M | 9.45M | 9.40M |
| Free cash flow | 3.47M | 24.84M | 10.41M | 12.89M | 6.16M | 34.91M |
| Dividends paid | -3.84M | -3.84M | -3.84M | -4.09M | -4.21M | -4.05M |
| Stock buybacks / issuance | 0 | -324.00K | -3.74M | -56.00K | -2.00K | -602.00K |
| Ending cash balance | 109.81M | 104.54M | 98.65M | 97.00M | 103.73M | 178.73M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 14.84 | 4.36 | 7.54 | 12.21 | 25.12 | 11.89 | 8.37 | 14.27 |
| ROA %i | 7.39 | 2.18 | 3.85 | 6.47 | 14.19 | 7.20 | 4.34 | 6.64 |
| ROIC %i | 11.58 | 3.80 | 5.64 | 9.04 | 18.79 | 9.43 | 7.14 | 9.78 |
| 5-year avg ROE %i | 13.14 | 10.83 | 9.44 | 9.49 | 12.81 | 12.22 | 13.02 | 14.37 |
| EBIT margin %i | 9.65 | 10.18 | 8.94 | 11.85 | 22.85 | 13.83 | 11.74 | 21.72 |
| FCF / sales %i | 4.92 | 4.25 | 9.42 | 7.32 | 8.98 | 10.04 | 5.22 | 7.22 |
| Current ratioi | 2.36 | 2.70 | 2.61 | 2.51 | 3.43 | 3.37 | 2.88 | 2.40 |
| Quick ratioi | 1.40 | 1.83 | 1.80 | 1.52 | 2.48 | 2.52 | 2.02 | 1.73 |
| Debt / assetsi | 21.44 | 26.15 | 24.57 | 22.91 | 20.22 | 18.69 | 38.53 | 35.71 |
| LT debt / equityi | 42.56 | 51.00 | 45.13 | 41.29 | 32.80 | 28.90 | 83.26 | 73.33 |
| Interest coveragei | 7.10 | 8.23 | 9.80 | 14.84 | 31.33 | 21.93 | 3.88 | 6.31 |
| Revenue CAGR (3Y) %i | -5.22 | -2.28 | 3.29 | 4.74 | 7.02 | 3.17 | 2.42 | 6.36 |
| Net income CAGR (3Y) %i | 9.27 | -24.30 | -0.12 | -3.31 | 90.24 | 26.07 | -3.16 | -9.03 |
| FCF CAGR (3Y) %i | -13.21 | -12.18 | 14.34 | 9.64 | 37.27 | 5.38 | -8.49 | -1.10 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 9.27 | 8.37 | 7.71 | 7.95 | 13.74 | 14.27 |
| ROA %i | 4.75 | 4.34 | 4.06 | 3.55 | 6.42 | 6.64 |
| ROIC %i | 7.10 | 7.14 | 7.37 | 6.49 | 9.62 | 9.78 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.30 | 11.74 | 11.77 | 14.51 | 21.47 | 21.72 |
| FCF / sales %i | 5.13 | 5.22 | 4.88 | 5.94 | 6.13 | 7.22 |
| Current ratioi | 3.40 | 2.88 | 2.87 | 2.87 | 3.05 | 2.40 |
| Quick ratioi | 2.36 | 2.02 | 1.94 | 1.97 | 2.06 | 1.73 |
| Debt / assetsi | 40.27 | 38.53 | 38.25 | 37.66 | 34.18 | 35.71 |
| LT debt / equityi | 89.68 | 83.26 | 82.39 | 81.79 | 67.55 | 73.33 |
| Interest coveragei | 5.21 | 3.88 | 3.09 | 3.68 | 5.73 | 6.31 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Electronics is the largest reported line at 53.28% of revenue, across 5 reported segments.
- Engraving & Hydraulics follows at 20.45%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Electronics53.28%
Engraving & Hydraulics20.45%
Aerospace & Defense15.14%
Scientific8.50%
Other2.63%
Region
United States58.41%
Asia Pacific26.17%
EMEA14.45%
Other Americas0.97%
Quote time 2026-10-08 06:32:51 · For reference only, not investment advice and not tailored to your situation.